Talk to us?

Oral and Maxillofacial Surgery - NEETMDS- courses
Oral and Maxillofacial Surgery

Management of Septic Shock

Septic shock is a life-threatening condition characterized by severe infection leading to systemic inflammation, vasodilation, and impaired tissue perfusion. Effective management is crucial to improve outcomes and reduce mortality. The management of septic shock should be based on several key principles:

Key Principles of Management

  1. Early and Effective Volume Replacement:

    • Fluid Resuscitation: Initiate aggressive fluid resuscitation with crystalloids (e.g., normal saline or lactated Ringer's solution) to restore intravascular volume and improve circulation.
    • Goal: Aim for a rapid infusion of 30 mL/kg of crystalloid fluids within the first 3 hours of recognition of septic shock.
  2. Restoration of Tissue Perfusion:

    • Monitoring: Continuous monitoring of vital signs, urine output, and laboratory parameters to assess the effectiveness of resuscitation.
    • Target Blood Pressure: In most patients, a systolic blood pressure of 90 to 100 mm Hg or a mean arterial pressure (MAP) of 70 to 75 mm Hg is considered acceptable.
  3. Adequate Oxygen Supply to Cells:

    • Oxygen Delivery: Ensure adequate oxygen delivery to tissues by maintaining hemoglobin saturation (SaO2) above 95% and arterial oxygen tension (PaO2) above 60 mm Hg.
    • Hematocrit: Maintain hematocrit levels above 30% to ensure sufficient oxygen-carrying capacity.
  4. Control of Infection:

    • Antibiotic Therapy: Administer broad-spectrum antibiotics as soon as possible, ideally within the first hour of recognizing septic shock. Adjust based on culture results and sensitivity.
    • Source Control: Identify and control the source of infection (e.g., drainage of abscesses, removal of infected devices).

Pharmacological Management

  1. Vasopressor Therapy:

    • Indication: If hypotension persists despite adequate fluid resuscitation, vasopressors are required to increase arterial pressure.
    • First-Line Agents:
      • Dopamine: Often the first choice due to its ability to maintain organ blood flow, particularly to the kidneys and mesenteric circulation. Typical dosing is 20 to 25 micrograms/kg/min.
      • Noradrenaline (Norepinephrine): Should be added if hypotension persists despite dopamine administration. It is the preferred vasopressor for septic shock due to its potent vasoconstrictive properties.
  2. Cardiac Output and Myocardial Function:

    • Dobutamine: If myocardial depression is suspected (e.g., low cardiac output despite adequate blood pressure), dobutamine can be added to improve cardiac output without significantly increasing arterial pressure. This helps restore oxygen delivery to tissues.
    • Monitoring: Continuous monitoring of cardiac output and systemic vascular resistance is essential to assess the effectiveness of treatment.

Additional Considerations

  • Supportive Care: Provide supportive care, including mechanical ventilation if necessary, and monitor for complications such as acute respiratory distress syndrome (ARDS) or acute kidney injury (AKI).
  • Nutritional Support: Early enteral nutrition should be initiated as soon as feasible to support metabolic needs and improve outcomes.
  • Reassessment: Regularly reassess the patient's hemodynamic status and adjust fluid and medication therapy accordingly.

Indications for PDL Injection

  1. Primary Indications:

    • Localized Anesthesia: Effective for one or two mandibular teeth in a quadrant.
    • Isolated Teeth Treatment: Useful for treating isolated teeth in both mandibular quadrants, avoiding the need for bilateral inferior alveolar nerve blocks.
    • Pediatric Dentistry: Minimizes the risk of self-inflicted injuries due to residual soft tissue anesthesia.
    • Contraindications for Nerve Blocks: Safe alternative for patients with conditions like hemophilia where nerve blocks may pose risks.
    • Diagnostic Aid: Can assist in the localization of mandibular pain.
  2. Advantages:

    • Reduced risk of complications associated with nerve blocks.
    • Faster onset of anesthesia for localized procedures.

Contraindications and Complications of PDL Injection

  1. Contraindications:

    • Infection or Severe Inflammation: Risks associated with injecting into infected or inflamed tissues.
    • Presence of Primary Teeth: Discuss the findings by Brannstrom and associates regarding enamel hypoplasia or hypomineralization in permanent teeth following PDL injections in primary dentition.
  2. Complications:

    • Potential for discomfort or pain at the injection site.
    • Risk of damage to surrounding structures if not administered correctly.
    • Discussion of the rare but serious complications associated with PDL injections.
  3. Management of Complications:

    • Strategies for minimizing risks and managing complications if they arise.

Epidural Hematoma (Extradural Hematoma)

Epidural hematoma (EDH), also known as extradural hematoma, is a serious condition characterized by the accumulation of blood between the inner table of the skull and the dura mater, the outermost layer of the meninges. Understanding the etiology, clinical presentation, and management of EDH is crucial for timely intervention and improved patient outcomes.

Incidence and Etiology

  • Incidence: The incidence of epidural hematomas is relatively low, ranging from 0.4% to 4.6% of all head injuries. In contrast, acute subdural hematomas (ASDH) occur in approximately 50% of cases.

  • Source of Bleeding:

    • Arterial Bleeding: In about 85% of cases, the source of bleeding is arterial, most commonly from the middle meningeal artery. This artery is particularly vulnerable to injury during skull fractures, especially at the pterion, where the skull is thinner.
    • Venous Bleeding: In approximately 15% of cases, the bleeding is venous, often from the bridging veins.

Locations

  • Common Locations:
    • About 70% of epidural hematomas occur laterally over the cerebral hemispheres, with the pterion as the epicenter of injury.
    • The remaining 30% can be located in the frontal, occipital, or posterior fossa regions.

Clinical Presentation

The clinical presentation of an epidural hematoma can vary, but the "textbook" presentation occurs in only 10% to 30% of cases and includes the following sequence:

  1. Brief Loss of Consciousness: Following the initial injury, the patient may experience a transient loss of consciousness.

  2. Lucid Interval: After regaining consciousness, the patient may appear to be fine for a period, known as the lucid interval. This period can last from minutes to hours, during which the patient may seem asymptomatic.

  3. Progressive Deterioration: As the hematoma expands, the patient may experience:

    • Progressive Obtundation: Diminished alertness and responsiveness.
    • Hemiparesis: Weakness on one side of the body, indicating possible brain compression or damage.
    • Anisocoria: Unequal pupil size, which can indicate increased intracranial pressure or brain herniation.
    • Coma: In severe cases, the patient may progress to a state of coma.

Diagnosis

  • Imaging Studies:
    • CT Scan: A non-contrast CT scan of the head is the primary imaging modality used to diagnose an epidural hematoma. The hematoma typically appears as a biconvex (lens-shaped) hyperdense area on the CT images, often associated with a skull fracture.
    • MRI: While not routinely used for initial diagnosis, MRI can provide additional information about the extent of the hematoma and associated brain injury.

Management

  • Surgical Intervention:

    • Craniotomy: The definitive treatment for an epidural hematoma is surgical evacuation. A craniotomy is performed to remove the hematoma and relieve pressure on the brain.
    • Burr Hole: In some cases, a burr hole may be used for drainage, especially if the hematoma is small and located in a favorable position.
  • Monitoring: Patients with EDH require close monitoring for neurological status and potential complications, such as re-bleeding or increased intracranial pressure.

  • Supportive Care: Management may also include supportive care, such as maintaining airway patency, monitoring vital signs, and managing intracranial pressure.

Maxillectomy

Maxillectomy is a surgical procedure involving the resection of the maxilla (upper jaw) and is typically performed to remove tumors, treat severe infections, or address other pathological conditions affecting the maxillary region. The procedure requires careful planning and execution to ensure adequate access, removal of the affected tissue, and preservation of surrounding structures for optimal functional and aesthetic outcomes.

Surgical Access and Incision

  1. Weber-Fergusson Incision:

    • The classic approach to access the maxilla is through the Weber-Fergusson incision. This incision provides good visibility and access to the maxillary region.
    • Temporary Tarsorrhaphy: The eyelids are temporarily closed using tarsorrhaphy sutures to protect the eye during the procedure.
  2. Tattooing for Aesthetic Alignment:

    • To achieve better cosmetic results, it is recommended to tattoo the vermilion border and other key points on both sides of the incision with methylene blue. These points serve as guides for alignment during closure.
  3. Incision Design:

    • The incision typically splits the midline of the upper lip but can be modified for better cosmetic outcomes by incising along the philtral ridges and offsetting the incision at the vermilion border.
    • The incision is turned 2 mm from the medial canthus of the eye. Intraorally, the incision continues through the gingival margin and connects with a horizontal incision at the depth of the labiobuccal vestibule, extending back to the maxillary tuberosity.
  4. Continuation of the Incision:

    • From the maxillary tuberosity, the incision turns medially across the posterior edge of the hard palate and then turns 90 degrees anteriorly, several millimeters to the proximal side of the midline, crossing the gingival margin again if possible.
  5. Incision to Bone:

    • The incision is carried down to the bone, except beneath the lower eyelid, where the orbicularis oculi muscle is preserved. The cheek flap is then reflected back to the tuberosity.

Surgical Procedure

  1. Extraction and Elevation:

    • The central incisor on the involved side is extracted, and the gingival and palatal mucosa are elevated back to the midline.
  2. Deepening the Incision:

    • The incision extending around the nose is deepened into the nasal cavity. The palatal bone is divided near the midline using a saw blade or bur.
  3. Separation of Bone:

    • The basal bone is separated from the frontal process of the maxilla using an osteotome. The orbicularis oculi muscle is retracted superiorly, and the bone cut is extended across the maxilla, just below the infraorbital rim, into the zygoma.
  4. Maxillary Sinus:

    • If the posterior wall of the maxillary sinus has not been invaded by the tumor, it is separated from the pterygoid plates using a pterygoid chisel.
  5. Specimen Removal:

    • The entire specimen is removed by severing the remaining attachments with large curved scissors placed behind the maxilla.

Postoperative Considerations

  • Wound Care: Proper care of the surgical site is essential to prevent infection and promote healing.
  • Rehabilitation: Patients may require rehabilitation to address functional issues related to speech, swallowing, and facial aesthetics.
  • Follow-Up: Regular follow-up appointments are necessary to monitor healing and assess for any complications or recurrence of disease.

Characteristics of Middle-Third Facial Fractures

Middle-third facial fractures, often referred to as "midfacial fractures," involve the central portion of the face, including the nasal bones, maxilla, and zygomatic arch. These fractures can result from various types of trauma, such as motor vehicle accidents, falls, or physical assaults. The following points highlight the key features and clinical implications of middle-third facial fractures:

1. Oedema of the Middle Third of the Face

  • Rapid Development: Oedema (swelling) in the middle third of the face develops quickly after the injury, leading to a characteristic "balloon" appearance. This swelling is due to the accumulation of fluid in the soft tissues of the face.

  • Absence of Deep Cervical Fascia: The unique anatomical structure of the middle third of the face contributes to this swelling. The absence of deep cervical fascia in this region allows for the rapid spread of fluid, resulting in pronounced oedema.

  • Clinical Presentation: In the early stages following injury, patients with middle-third fractures often present with similar facial appearances due to the characteristic swelling. This can make diagnosis based solely on visual inspection challenging.

2. Lengthening of the Face

  • Displacement of the Middle Third: The downward and backward displacement of the middle third of the facial skeleton can lead to an increase in the overall length of the face. This displacement forces the mandible to open, which can result in a change in occlusion, particularly in the molar region.

  • Gagging of Occlusion: The altered position of the mandible can lead to a malocclusion, where the upper and lower teeth do not align properly. This can cause discomfort and difficulty in chewing or speaking.

  • Delayed Recognition of Lengthening: The true increase in facial length may not be fully appreciated until the initial oedema subsides. As the swelling decreases, the changes in facial structure become more apparent.

3. Nasal Obstruction

  • Blood Clots in the Nares: Following a middle-third fracture, the nares (nostrils) may become obstructed by blood clots, leading to nasal congestion. This can significantly impact the patient's ability to breathe through the nose.

  • Mouth Breathing: Due to the obstruction, patients are often forced to breathe through their mouths, which can lead to additional complications, such as dry mouth and increased risk of respiratory infections.

Types of Hemorrhage

Hemorrhage, or excessive bleeding, can occur during and after surgical procedures. Understanding the different types of hemorrhage is crucial for effective management and prevention of complications. The three main types of hemorrhage are primary, reactionary, and secondary hemorrhage.

1. Primary Hemorrhage

  • Definition: Primary hemorrhage refers to bleeding that occurs at the time of surgery.
  • Causes:
    • Injury to blood vessels during the surgical procedure.
    • Inadequate hemostasis (control of bleeding) during the operation.
  • Management:
    • Immediate control of bleeding through direct pressure, cauterization, or ligation of blood vessels.
    • Use of hemostatic agents or sutures to secure bleeding vessels.
  • Clinical Significance: Prompt recognition and management of primary hemorrhage are essential to prevent significant blood loss and ensure patient safety during surgery.

2. Reactionary Hemorrhage

  • Definition: Reactionary hemorrhage occurs within a few hours after surgery, typically when the initial vasoconstriction of damaged blood vessels subsides.
  • Causes:
    • The natural response of blood vessels to constrict after injury may initially control bleeding. However, as the vasoconstriction diminishes, previously damaged vessels may begin to bleed again.
    • Movement or changes in position of the patient can also contribute to the reopening of previously clamped vessels.
  • Management:
    • Monitoring the patient closely in the immediate postoperative period for signs of bleeding.
    • If reactionary hemorrhage occurs, surgical intervention may be necessary to identify and control the source of bleeding.
  • Clinical Significance: Awareness of the potential for reactionary hemorrhage is important for postoperative care, as it can lead to complications if not addressed promptly.

3. Secondary Hemorrhage

  • Definition: Secondary hemorrhage refers to bleeding that occurs up to 14 days postoperatively, often as a result of infection or necrosis of tissue.
  • Causes:
    • Infection at the surgical site can lead to tissue breakdown and erosion of blood vessels, resulting in bleeding.
    • Sloughing of necrotic tissue may also expose blood vessels that were previously protected.
  • Management:
    • Careful monitoring for signs of infection, such as increased pain, swelling, or discharge from the surgical site.
    • Surgical intervention may be required to control bleeding and address the underlying infection.
    • Antibiotic therapy may be necessary to treat the infection and prevent further complications.
  • Clinical Significance: Secondary hemorrhage can be a serious complication, as it may indicate underlying issues such as infection or inadequate healing. Early recognition and management are crucial to prevent significant blood loss and promote recovery.

Transoral Lithotomy: Procedure for Submandibular Duct Stone Removal

Transoral lithotomy is a surgical technique used to remove stones (calculi) from the submandibular duct (Wharton's duct). This procedure is typically performed under local anesthesia and is effective for addressing sialolithiasis (the presence of stones in the salivary glands).

Procedure

  1. Preoperative Preparation:

    • Radiographic Assessment: The exact location of the stone is determined using imaging studies, such as X-rays or ultrasound, to guide the surgical approach.
    • Local Anesthesia: The procedure is performed under local anesthesia to minimize discomfort for the patient.
  2. Surgical Technique:

    • Suture Placement: A suture is placed behind the stone to prevent it from moving backward during the procedure, facilitating easier access.
    • Incision: An incision is made in the mucosa of the floor of the mouth, parallel to the duct. Care is taken to avoid injury to surrounding structures, including:
      • Lingual Nerve: Responsible for sensory innervation to the tongue.
      • Submandibular Gland: The gland itself should be preserved to maintain salivary function.
  3. Blunt Dissection:

    • After making the incision, blunt dissection is performed to carefully displace the surrounding tissue and expose the duct.
  4. Identifying the Duct:

    • The submandibular duct is located, and the segment of the duct that contains the stone is identified.
  5. Stone Removal:

    • A longitudinal incision is made over the stone within the duct. The stone is then extracted using small forceps. Care is taken to ensure complete removal to prevent recurrence.
  6. Postoperative Considerations:

    • After the stone is removed, the incision may be closed with sutures, and the area is monitored for any signs of complications.

Complications

  • Bacterial Sialadenitis: If there is a secondary infection following the procedure, it can lead to bacterial sialadenitis, which is an inflammation of the salivary gland due to infection. Symptoms may include pain, swelling, and purulent discharge from the duct.

Explore by Exams